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ABSTRACT Although physical activity is considered an important therapeutic target in chronic
obstructive pulmonary disease (COPD), what ‘‘physical activity’’ means to COPD patients and how their
perspective is best measured is poorly understood. We designed a conceptual framework, guiding the
development and content validation of two patient reported outcome (PRO) instruments on physical
activity (PROactive PRO instruments).
116 patients from four European countries with diverse demographics and COPD phenotypes
participated in three consecutive qualitative studies (63% male, age mean¡SD 66¡9 years, 35% Global
Initiative for Chronic Obstructive Lung Disease stage III–IV). 23 interviews and eight focus groups (n554)
identified the main themes and candidate items of the framework. 39 cognitive debriefings allowed the
clarity of the items and instructions to be optimised.
Three themes emerged, i.e. impact of COPD on amount of physical activity, symptoms experienced
during physical activity, and adaptations made to facilitate physical activity. The themes were similar
irrespective of country, demographic or disease characteristics. Iterative rounds of appraisal and refinement
of candidate items resulted in 30 items with a daily recall period and 34 items with a 7-day recall period.
For the first time, our approach provides comprehensive insight on physical activity from the COPD
patients’ perspective. The PROactive PRO instruments’ content validity represents the pivotal basis for
empirically based item reduction and validation.
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Introduction
Chronic obstructive pulmonary disease (COPD) affects ,10% of people and represents the third leading
cause of death worldwide [1, 2]. Besides chronic airflow limitation and a range of pathological changes in
the lung, extrapulmonary consequences contribute significantly to disease progression and different disease
phenotypes [3]. Reduced physical activity might trigger these extrapulmonary consequences, and is
associated with an increased risk of co-morbidities, (re)hospitalisation, and all-cause or respiratory
mortality [4–8].
Despite the paucity of data, it is intuitively clear that physical activity constitutes an important outcome not
only to clinicians, but also to COPD patients, given the direct impact of physical activity problems on their
daily functioning. For instance, the large multinational PERCEIVE (Perception of Exacerbations of Chronic
Obstructive Pulmonary Disease) study conducted telephone interviews with .1000 patients, and found
that, besides shortness of breath (78%), COPD patients most frequently complained about their inability to
complete the activities they enjoy because of their illness [9]. Improvement in physical activity might
therefore be regarded as an important patient-centred therapeutic target for both pharmacological and non-
pharmacological interventions.
The guidelines on patient reported outcome (PRO) instrument development put forward by the US Food
and Drug Administration (FDA) clearly indicate that PRO instruments should be based upon a conceptual
framework [10]. The European Medicines Agency (EMA) defines a PRO as ‘‘any outcome directly evaluated
by the patient and based on the patient’s perception of a disease and its treatment(s)’’ [11]. A conceptual
framework defines the PRO concept under investigation in an unambiguous way and visualises the
concept(s) measured by the PRO instrument in a diagram representing the relationships between the main
concept, the domains and/or sub-domains, from which items and their scoring can be derived [10, 12]. In
the absence of such a framework, it is questionable what exactly a PRO measures, which also has
repercussions for labelling claims. Thus, a PRO instrument should be well-thought out and planned,
rigorously developed and have good content validity, demonstrating that the PRO instrument’s items and
domains are appropriate and comprehensive, relative to its intended measurement concept, population and
use [10, 13, 14]. The whole process should be steered by direct information from patients using appropriate
qualitative research methodology.
Many self-reported instruments on physical activity or related concepts have been published to date. Recent
systematic reviews, however, highlighted that their content and validity for use in COPD patients is
questionable due to the lack of a conceptual framework underpinning the items [15, 16]. Clinicians and
researchers often cite the physical activity definition of CASPERSEN et al. [17] as ‘‘any bodily movement
produced by skeletal muscles resulting in energy expenditure beyond resting energy’’. While this definition
has value in that it reflects a crucial aspect of physical activity in terms of maintenance of health, it is clear
that this definition does not capture all aspects or ‘‘domains’’ of the concept that patients with COPD deem
relevant. A systematic review specifically looking for conceptual frameworks on physical activity could not
find any useful frameworks that could guide the development of a new PRO instrument on physical activity
[18]. Therefore, the Innovative Medicines Initiative PROactive project aimed to design a conceptual
framework underpinning the item generation and content validation process of the PROactive PRO
instruments to capture physical activity from the perspective of patients with COPD [19].
Methods
In concordance with the International Society for Pharmacoeconomics and Outcomes Research (ISPOR)
recommendations on establishing content validity of newly designed PRO instruments [13, 14], three steps
were completed using a qualitative research methodology to: 1) elicit the key themes to inform the
conceptual framework; 2) guide the item development process; and 3) assess the patients’ understanding of
the draft PROactive PRO instruments. Reporting of the methodology and results are in line with the
Consolidated Criteria for Reporting Qualitative Studies guidelines [20].
Design
Step 1 used a grounded theory approach [21–23]. Semi-structured, one-to-one-interviews and focus groups
with patients representing the broad spectrum of COPD were conducted to unravel their ‘‘lived experience’’
or detailed account of physical activity. While interviews provide in-depth information about an
individual’s experience, focus groups allow participants to compare their experiences and use quotes from
others as cues to express their own views [20]. Examples of core questions asked include: What does
physical activity mean to you? Do you experience limitations in your activities? If so, what are these?
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Step 2 combined content analysis of the quotes from patients participating in step 1 with expert input and
extensive literature searches [15, 16, 24, 25] to create the items, response options and recall period for the
PROactive PRO instruments.
Step 3 consists of cognitive debriefings of the initially derived items and instructions to target the mental
processes respondents use when completing PRO instruments (i.e. comprehension, retrieval, judgment and
response) [26, 27]. ‘‘Thinking aloud’’ and probing techniques were applied, inviting a patient to verbalise
any word in their minds when executing a task [28]. Examples of questions asked include: Can you explain
in your own words what this question means to you? What were you thinking when reading this question?
Do the response options make sense to you? Is this question relevant for you based on your own experience
of physical activity?
Sample and setting
In each step, we enrolled patients from four different countries with varying geographical characteristics and
care settings (i.e. the Netherlands, UK, Belgium and Greece), using the following inclusion criteria: age
o40 years, physician’s diagnosis of COPD, fluent in the local language, and willing and able to provide
written informed consent. Exclusion criteria were: age ,40 years, institutionalised patients (nursing home
or psychiatric unit), patients with documented dementia or other mental impairment, patients in palliative
care, or patients with major co-morbidities that, in the physician’s opinion, would make it difficult to
capture aspects of physical activity that are specific for COPD (e.g. amputation and advanced heart failure).
In order to capture the heterogeneity of COPD disease and guarantee sample representativeness, a
multidisciplinary expert panel was held during the 2009 European Respiratory Society Congress to define
the key demographic, clinical and psychosocial phenotyping criteria and their measurement, as well as the
suggested quota of patients fulfilling each criterion (table 1). The agreed measurement methodology is
described in detail elsewhere [29, 30].
The main characteristics for theoretical sampling were age (at least 30% aged ,60 years), sex (at least 40%
female) and 60–70% of patients in Global Initiative for Chronic Obstructive Lung Disease (GOLD) severity
classification II and III [31], as these patients are more likely to participate in future drug development
studies implementing the PROactive PRO instruments. Eligible patients were identified via postings on
websites of patient organisations, screening of databases of secondary or tertiary care hospitals and through
a primary care network of general practitioners.
Development of interview guides and training of the interviewers
The interview guides for all three steps were developed in an iterative fashion based on qualitative research
literature, expert input and pilot testing. Interviewers not involved in direct patient care were trained by two
experienced qualitative researchers over four non-consecutive days using role play, hands-on practice with
volunteering patients, and feedback on pilot interviews.
Ethics
The project’s ethics board and Patient Input Platform [32] and the research ethics committees of the
participating centres approved the protocol.
Transcription and translation
Interviews were audiotaped and transcribed verbatim by the interviewer. All elements that could lead to the
participant’s identification were removed (e.g. names and places). Given the project’s multinational context,
transcripts were translated by a certified translation company into English prior to data analysis, using
established guidelines [33]. Translations were checked to ensure that no nuances or meaningful quotes were
lost or altered. The conceptual framework and corresponding items were designed in English, but translated
into the study languages prior to each round of cognitive debriefings. The final item lists are available in
English, Dutch (for the Netherlands and Belgian) and Greek.
Statistical analysis
SAS (version 9.3; SAS Institute Inc., Cary, NC, USA) was used to summarise the sample characteristics
descriptively. The computer programme Atlas.ti version 6.0 (www.atlasti.com/index.html) facilitated the
qualitative data analysis.
Step 1: eliciting the key themes to inform the conceptual framework
The one-to-one transcripts were first read individually, marking text fragments referring to physical activity,
and designing a draft proposal of a coding dictionary. Proposed codes were discussed with the team, after
which the agreed upon coding dictionary was programmed into the Atlas.ti Software. A first round of
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coding of all interviews was performed independently within a 14-day period by pairs of team members,
followed by a second round of coding using a slightly revised coding dictionary. A similar stepwise approach
was used to analyse the focus groups. Codes for which saturation was reached were classified into
meaningful themes, representing the different aspects of the concept physical activity (i.e. topics addressed
by the majority of patients and supported by a large number of quotes). Regular meetings with the entire
team (interviewers and non-interviewers) were scheduled to avoid interpretation bias. Results were
discussed until consensus on the conceptual framework was reached. The framework was subsequently
endorsed by the members of the project’s consortium, the advisory board, ethics board and the Patient
Input Platform [32].
TABLE 1 Phenotyping criteria, measurement and quota for the one-to-one interviews, focus groups and cognitive debriefings
Characteristics Measurement Target quota# Total group Interviews Eight focus
groups
Debriefings
Subjects n 116 23 54 39
Country
UK 30 (25.9) 7 (30.4) 13 (24.1) 11 (28.3)
Netherlands 31 (26.6) 8 (34.8) 15 (27.7) 8 (20.5)
Belgium 30 (25.9) 8 (34.8) 13 (24.1) 10 (25.6)
Greece 24 (20.6) 13 (24.1) 10 (25.6)
Females Medical chart 40% 41 (35.3) 9 (39.1) 19 (35.2) 13 (33.3)
Age years Medical chart 66¡8.5 66.8¡10.2 66.4¡8.2 65.1¡7.8
f60 30% 22 (18.9) 7 (30.4) 8 (14.8) 7 (17.9)
Education Self-report
Low f15 years o20% 23 (20)" 4 (17.5) 11 (20.4) 9 (23.7)
Moderate f18 years 62 (54) 17 (73.9) 27 (50.0) 17 (44.7)
High .18 years 30 (26) 2 (8.6) 16 (29.6) 12 (31.6)
Married or cohabiting Self-report 20% single 81 (69.8) 17 (73.9) 37 (68.5) 27 (69.2)
Employment Self-report 20% working 25 (21/7)" 6 (26.1) 9 (16.7) 9 (23.1)
Lung function Spirometry and diffusion capacity
FEV1 % 58.4¡21.0+ 59.2¡21.1 58.1¡21.4 58.4¡20.8
FRC % 143.2¡110.51 142.3¡32.3 154.9¡150.8 124.7¡29.0
TLC % 109.9¡20.2e 114.5¡18.9 109.8¡21.1 107.4¡19.6
TLCO % 68.3¡36.6## 61.9¡26.2 56.8¡23.0 90.7¡48.8
Exercise capacity 6MWD 423.5¡114.9"" 452¡145 412¡112 423.8¡99.2
GOLD stage Lung function
GOLD I FEV1o80% 10–20% 20 (17.2) 5 (21.8) 10 (18.5) 5 (12.7)
GOLD II FEV1 50–79% o60% 50 (43.1) 9 (39.1) 23 (42.6) 18 (46.1)
GOLD III FEV1 30–49% o60% 29 (25.0) 5 (21.8) 16 (29.6) 8 (20.6)
GOLD IV FEV1 ,30% 12 (10.4) 3 (13.0) 5 (9.3) 4 (10.3)
Unknown 5 (4.3) 1 (4.3) 10 (18.5) 4 (10.3)
BODE index FEV1,6MWD,MRCdyspnoeascale,BMI 2.8¡2.1++ 2.9¡2.7 2.7¡2.1 2.8¡1.9
Score 0–4 40% 56 (52.3) 12 (57.1) 27 (54) 17 (47.2)
Current smokers Medical chart o25% 21 (18.4)11 5 (21.8) 11 (20.4) 5 (12.8)
Exacerbations within last
12 months
Medical chart and self-report 20% 36 (31.6)11 6 (26.1) 15 (28.3) 15 (39.5)
Long-term oxygen use Medical chart 10% 17 (14.8) 3 (13) 11 (20.4) 3 (7.9)
Structured pulmonary
rehabilitation programme
Medical chart and self-report 20% (past and
present)
40 (34.4) 6 (28) 19 (35.1) 10 (25.6)
BMI kg?m-2 Medical chart 27.4¡5.311 26.4¡6.0 27.2¡5.0 28.2¡5.4
Low ,20 20% 9 (7.9) 3 (13) 4 (7.4) 2 (5.4)
Obese o30 20% 32 (28.0) 6 (26) 15 (27.8) 11 (29.7)
Co-morbidity Charlson co-morbidity index 3.6¡1.4 3.4¡1.1 3.5¡1.3 3.7¡1.6
Depressive symptoms HADS scoreo8 o10% 5.5¡3.6ee 5.3¡4.4 5.6¡3.2 5.3¡3.6
HADS score o8 29 (25.9) 7 (30.4) 15 (27.2) 7 (20.6)
Data are presented as n (%) or mean¡SD, unless otherwise stated. The phenotyping criteria methodology is described elsewhere [29, 30]. FEV1:
forced expiratory volume in 1 s; FRC: functional residual capacity; TLC: total lung capacity; TLCO: transfer factor of the lung for carbon monoxide;
GOLD: Global Initiative for Chronic Obstructive Lung Disease; BODE: BMI, airflow obstruction, dyspnoea, exercise capacity; BMI: body mass index;
HADS: Hospital Anxiety and Depression Scale; 6MWD: 6-min walk distance; MRC: Medical Research Council. #: determined based on consensus
among interdisciplinary experts in chronic obstructive pulmonary disease. Targets were only used to guarantee sample representativeness by
ensuring that patients with widely varying demographic, disease and psychosocial characteristics were sufficiently represented. ": n5115; +:
n5113; 1: n599; e: n5102; ##: n5107; "": n5110; ++: n5107; 11: n5114; ee: n5112.
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Step 2: item development process
Guided by the themes depicted in the conceptual framework, the participants’ ‘‘quotes’’ from the interviews
and focus groups were used to form the wording of the items, following a sequence of drafting, review,
modification, re-review and consensus. Although the qualitative data formed the backbone for decision
making, the team also consulted evidence on possible response options, optimal recall period, and wording
of items used in existing self-reported instruments [15, 16, 24, 25]. Revisions made to the original set of
draft items were documented in an item tracking matrix.
Step 3: assess the patients’ understanding of the draft PROactive PRO instruments
Comments made during the cognitive debriefings on the clarity of wordings, instructions and response
options were tabulated by each interviewer into the following categories: 1) instructions were not
understood correctly; 2) respondents did not understand the item and required examples for clarification;
and 3) respondents encountered difficulties with the response options. After the first round of debriefings,
the English version item pool was revised, incorporating all remarks made by at least two participants.
Debriefing on the updated version was undertaken by three native English speaking patients before
completing the translations, followed by a new round of debriefings in each country. Remarks made during
this second round of debriefings were discussed iteratively with the team members and experts, until the
final item list was approved and endorsed by all consortium partners. The Flesch–Kincaid formula was used
to evaluate readability of the item lists using an online calculator [34]. Reading ease is expressed by a score
from 0–100, with higher scores indicating a better readability. A score between 60 and 70 is easily
understood by 13–15-year-old students, while a score of ,30 is best understood by university graduates.
Grade level is also estimated, for instance, with a grade 8 reading level corresponding with an average UK or
US student of 13–14 years of age in education year 8 [35].
Results
23 one-to-one interviews, eight focus groups with 54 patients and 39 debriefings were conducted (total
sample n5116, 63% male, age mean¡SD 66¡9 years, 35% GOLD stage III-IV) (table 1). Additional
phenotyping characteristics are presented in table 1.
Step 1: eliciting the key themes to inform the conceptual framework
Figure 1 represents the three core themes and their respective sub-themes directly reflecting the patients’
experience of physical activity, i.e. ‘‘amount of physical activity’’ (what activities they do), ‘‘symptoms
during physical activity’’ (how do they feel when doing these activities), and ‘‘need for physical adaptations’’
(how they perform these activities) (fig. 1). The activities affected first were climbing the stairs and walking
(first ‘‘uphill’’ and then also on the flat). Yet, patients reported that with disease progression almost all
physical activities of daily life became affected, such as carrying objects, household activities and, ultimately,
self-care activities such as dressing or bathing. When being physically active, patients also noticed symptoms
including breathlessness, physical exhaustion, fatigue or lack of strength. Some patients also experienced leg
problems (including leg fatigue). Patients noticed variability in good and bad days, reported that symptoms
are unpredictable and gradually worsen over time. Patients adapt their physical activities by pacing or
slowing down, interrupting their activities to take a break to recover, or allowing a longer recuperation
period. Some patients also use aids (e.g. a rollator or electrical bike) to facilitate physical activities, but a lot
of activities need to be given up over time as patients are no longer able to perform them. Reduced amount
of activities, activity-related symptoms and physical adaptation mechanisms are all interrelated, as
illustrated by the return arrows. Table 2 shows which themes are mentioned most frequently and table 3
presents examples of quotes supporting the themes and their interrelationships.
External factors such as humid air, extreme temperatures and disease-related factors, including co-morbid
conditions (e.g. back pain) and exacerbations of their COPD, may aggravate problems with physical activity.
As an emotional or social consequence of their activity-related problems, some patients reported feeling sad,
frustrated, dependent or isolated and family members/friends/other people did not understanding they
could no longer do what they used to do, while other patients received practical help in carrying out
activities. Although these influencing factors and consequences are important, they do not capture the
concept of physical activity directly. Therefore, they were not considered part of the conceptual framework.
Themes were remarkably similar irrespective of country, sex, age and GOLD stage. This illustrates that
physical activity is probably a universally applicable concept that is relevant for the majority of patients with
COPD, and that patients use a common language to talk about physical activities (table 2). The activity
‘‘cycling’’ represented an exception. Patients in the Netherlands, and to a lesser extent in Belgium, noted a
reduced ability to cycle, while this activity was not mentioned in the UK and Greece, rendering this activity
an unsuitable candidate item. Although all patients noticed problems when having to walk uphill, cognitive
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debriefing revealed that the meaning of ‘‘uphill’’ differed between countries (e.g. a small slope versus a steep
hill). Hence, this observation warranted the need for careful wording of the item, so that ‘‘uphill’’ has the
same meaning irrespective of geographical location.
Step 2: item development process
Various versions of the item bank were drafted between August and November 2010. First, 1466 candidate
items were extracted from all transcripts as well as existing instruments, and tabulated (table 2) [15, 16].
Each candidate item was carefully reviewed by the team for eligibility, resulting in a reduced list of 951
items, which was subsequently further reduced to 448 after a second screening. Reasons for removing quotes
were: 1) not capturing the main themes and subthemes (e.g. items referring to determinants, consequences
or past experiences, ‘‘I used to walk much faster’’, ‘‘I feel embarrassed when I have to stop to catch my
breath’’); 2) vague formulations (‘‘I had to become a lot calmer’’, ‘‘it doesn’t work when I want to go
faster’’); 3) items with a very specific content (‘‘I cannot go to city XX or YY anymore’’); and 4) quotes
referring to related, but different concepts (e.g. beliefs about or perceived ability rather than actual physical
activity e.g. ‘‘I think I would be able to walk 5 km’’). Next, quotes with similar wordings were grouped
within each topic. For instance, the topic ‘‘breathlessness’’ included quotes grouped as ‘‘breathlessness’’,
‘‘out of breath’’ or ‘‘puffing’’. Another example referred to reduced amount: ‘‘it is difficult to’’, ‘‘I have
problems to’’, ‘‘I am not able to’’. Grouped items were re-reviewed iteratively and changes were
documented in detailed tables, until 30 items for a daily assessment and 34 for the 7-day clinic visit
assessment were ready to undergo cognitive debriefing. Final decisions on wording were made based on the
number of quotes with similar phrasings, easiness to read the items, and extensive discussions with the
consortium and advisory board.
How much walking did you do outside today?
How many tasks did you do inside the house today?
How many tasks did you do outside the house today?
How much physical leisure activity did you do today?
How much difficulty did you have getting dressed today?
How much difficulty did you have with carrying things you needed to today?
How much difficulty did you have climbing stairs today? (If climbed stairs today)
How much difficulty did you have showering/bathing today? (Depending on whether patient usually
  baths or showers and whether they did this)
How much difficulty did you have bending over today?
How much difficulty did you have washing today?
How much difficulty did you have walking up a small slope today?
How much difficulty did you have when hurrying today?
  In the past 7 days, how much difficulty did you have getting out and about?
How breathless were you in general during your activities today?
How often did you lack physical strength to do things today?
How often did you experience lack of strength in your legs during your physical activity today?
How tired were you in general during your activities today?
How breathless were you when walking on level ground inside and outside today?
How breathless were you when climbing stairs today? (If climbed stairs today)
  In the past 7 days, how often did you cough during your physical activities?
How often did you avoid doing activities because of your lung problems today?
How often did you have to take breaks during your physical activities today?
How often did you have to pace yourself during your physical activities today?
How often did your lung problems prevent you from doing activities that you needed to do today?
How often did you have to slow down while walking today?
How much time did you need to recover from your physical activities today?
Did you need to spread your activities throughout the day today because of your lung problems?
Did your lung problems stop you from doing the physical activities that you wanted to do today?
How many puffs of [insert name of rescue medication here] in addition to your regularly used
  medication did you need to take for your physical activities today? (If on medication only)
Did you need to consider your lung problems when you planned your activities today?
How much help from others did you need with any of your activities today?
  In the past 7 days, how often did you exercise to maintain or improve your physical condition?
  In the past 7 days, how often did you use aids to facilitate your physical activities?
  In the past 7 days, how often did you overexert yourself during your practical activities?
Amount
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FIGURE 1 Conceptual framework on chronic obstructive pulmonary disease (COPD) patients’ experiences of physical activity. Items for the clinic visit patient
reported outcome (PRO) are similar to the items of the PRO to be completed on a daily basis, with the exception of the items in bold, which only appear in the
clinic visit PRO. In addition, examples to clarify the meaning of some items are left out due to space restrictions.
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In view of the recall period, two different versions of the PRO instrument were designed to measure experience
with PA, i.e. a daily patient diary and a 7-day recall clinic visit version. Patients who were interviewed noted
large day-to-day fluctuations in the amount of activities they could do and the level of symptoms experienced
while being physically active. This necessitates a variety of adaptation mechanisms in order to overcome their
limitations. For instance, patients mentioned feeling extremely breathless one day while walking, while on
other days they could walk longer without feeling too breathless or without needing to take many breaks. Also,
when soliciting patients’ opinions on recall periods, many suggested developing an instrument that needed to
be completed daily at the end of each day. These patient-generated data justify the development of a PRO
instrument on COPD patients’ experiences of physical activity with a 1-day recall period.
Yet, not all activities that are important to patients are conducted on a daily basis, such as household tasks
or leisure activities, with some activities tending to follow a weekly cycle (e.g. cleaning the house on Friday,
visiting friends on Tuesday, etc.). Moreover, some adaptations also refer to longer time periods, like time
needed to recover, or formally prescribed exercises. In addition, many patients pointed towards fluctuations
over longer periods of time on top of day to day variations, and differentiated between better and worse
TABLE 3 Examples of quotes to support the themes and subthemes of the conceptual framework
Quotes Themes
‘‘But, you know, I take things easy, right. If I have to climb stairs I have more difficulty than I have here (i.e. in the hospital), you
see. Today I can take the sun pretty well, I mean, I can walk, but once it goes uphill I’m in trouble. When I get home I have to
climb a hill, 5 metres up. First it goes slightly up and then I have to climb stairs but then I have to go and sit down for a bit. I do
feel it then. I mean, that I’m out of breath. It only takes 5 minutes, but then I have to lie down again – that’s at 7 o’clock in the
morning – and then I recover.’’
(Belgium, interview 3: male, age 65 years, GOLD stage II)
Doing things slower
Difficulty climbing stairs
Difficulty going uphill
Taking breaks/time needed to recover
‘‘To make myself clear, because we shouldn’t lie now, I’m not at the level I want to be. To make it… you therefore divide it into
breaks, you stop at the stairs with the bags and you begin again… At the stairs or, I don’t know, let’s say, in the street where I
carry the trolley from the farmers’ market, let’s say, it’s a distance of 200 to 300 meters, 400 to 500. Because even at the
farmer’ market you come and go, you come and go. You don’t stay in one place, because in that case there’s no point going to
the farmers’ market… And when I get tired, I look for a crate, let’s say, at the farmers’ market. If I’m tired, I take a break. I sit
on the crate… oof… I say something silly to an Olympiakos fan, to a Panathinaikos fan and I start again and make it to the
house. That is, I try to gain, let’s say, metres, to give myself some time and to catch my breath and to raise my morale.’’
(Greece, focus group 1: male, aged 57 years, GOLD stage II)
Taking breaks
Problems with walking
Difficulty climbing stairs
Tiredness
Time needed to recover
Breathlessness
‘‘I live on my own, so my housekeeping must also be done. For example, when I have to mow the lawn, I just have a small garden
and I have to mow that, and the neighbours have to too. Otherwise I get discredited so that does have to happen. And then I do
that in three goes. So do a bit, and then I go back inside, lie on the bench and then, eh, then I think, yes I am back, and then I go
back. Then I do it… What used to take a quarter of an hour, that garden, I now do in more than an hour and a half. I pant, then I
pant, so I then quit. Now I almost never want to walk. And cycling, that goes very well, but that is with a cycle with support.
That is, that is the invention of the century.’’
(Netherlands, focus group 2: male, aged 71 years, GOLD stage I)
Problems with tasks outside and walking
Taking breaks/interrupting activities
Time needed to recover
Breathlessness
Using aids (e.g. electric bike)
‘‘Getting dressed and undressed when I’m so short of breath, I need my wife for that as well, you know. Also when you go for a
bath and you’re sitting there in a small room with all the steam and less oxygen… that is actually the thing I’m most sensitive
to…getting my breath. So that’s not something that I go and do every day, you see! I look at that as split tasks, you know.
Having a bath, drying yourself and whatever, you have to divide that up as well, right. And that’s bending and straightening up,
isn’t it. Because how else are you going to get your feet dry? And the days that I do those things I know that I mustn’t plan too
many other things.’’
(Belgium, interview 5: male, aged 64 years, GOLD stage IV)
Spreading and planning activities
Difficulties bathing and getting dressed
Breathlessness
Difficulties bending over
Needing help from others
[About social activities] ‘‘I had to give them all up. I’ve done a lot of work outside and that. I had the pigeons but had to gee [give]
them up right away. There are a lot of things I’ve had to give up, you know. Well playing football, like football and that. Can’t
walk along the corridor, never mind run. And as I said, when you go out with your wife and she’s carrying two big bags and
your walking along there with nothing, people must say to themselves ‘‘oh look at that man his wife carrying the bags and
he’s got nothing’’, but at the end of the day they dinnae ken [don’t know] what’s happening inside you!’’
(UK, focus group 2: male, aged 65 years, GOLD stage II)
Giving up the things you like
Problems with walking
Needing help from others
‘‘There a great deal of things that are the same. I do things and of course I am not 20 any longer, but I do things. It’s normally
more slowly and indeed, and then I do take a puff, but it sometimes it does take you by surprise. Er, it’s happened to me a few
times as if everything pinches tightly. It has happened a few times now, so I normally try to make sure that it doesn’t happen
again. But with extra efforts, walking on the stairs and like that, it does happen to me. Really serious things, then I think, ‘‘rest
for a bit’’ because otherwise it won’t be good. And one time it goes fine and the other time, then is [pretends to be out of
breath]. That is mad, it is never actually the same.’’
(Netherlands, focus group 2: male, aged 63 years, GOLD stage II)
Doing things slower
Taking medication
Breathlessness
Difficulty climbing stairs
‘‘I couldn’t walk. That means that I’ve got a fold up wheelchair, ehm which I use quite a lot. I’ve now bought myself a scooter, like
yours P5, which I find I am more independent on a scooter than in a wheelchair, you know, I can stop at a shop and say I’m
here [laughs] and I don’t have to shout ‘‘stop’’. So, that’s the only way I can go shopping now, I can’t I can’t walk through a
shopping centre without… the breathing is bad but it it’s also it’s is agony for me because your … your struggling to breathe,
you have to keep stopping and people stop and look at you and you feel like dirt on the floor [laughs]. It is bad, very very bad
when you can’t breathe.’’
(UK focus group 2: female, aged 70 years, GOLD stage III)
Difficulties walking
Using aids
Breathlessness
Taking breaks/interrupting activities
‘‘So, you are breathing with difficulty and you are fighting to recover from your legs and from your breathing so that you can walk
another ten metres. And the same again at the next ten metres. A stop. You can’t go any longer. Concerning stairs… um…
um… in the morning I think and say, ‘‘I will go, let’s say, two to ten steps to go there, but how will I go?’’ Because I must also
make such stops, and I must know where to sit.’’
(Greece, focus group 1: male, aged 72 years, GOLD stage II)
Leg problems
Breathlessness
Problems with walking
Taking breaks and planning activities
Time needed to recover
GOLD: Global Initiative for Chronic Obstructive Lung; Disease.
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periods of time. For instance, some patients talked about their physical activity in the weeks before
hospitalisation for an exacerbation (e.g. they could do less activities and experienced significant
breathlessness and exhaustion while being active), the recovery period (slowly performing some activities
again), or the impact of rehabilitation on their physical activity levels (e.g. learning new ways to adapt in
order to maximise their level of physical activity without increasing their symptoms). This patient-driven
information justifies the development of a PRO that is able to capture these variations over longer periods
of time. Admittedly, patients had varying opinions on the best recall period. This is in line with published
evidence, underscoring that there is not a ‘‘one size fits all approach’’ [24], and that the appropriate length
of the recall period very much depends on the concept being studied. For fluctuating phenomena, such as
symptoms or activities of daily living, it is recommended not to use recall periods that go beyond 7 days,
justifying our choice for a 7-day recall period for the clinic visit PRO instrument [24].
Different response options were explored based on expert opinion and a critical analysis of existing
literature. In line with evidence-based recommendations [25], the team decided to use a five-point labelled
Likert scale, reflecting a gradually reduced amount of physical activity, increasing symptoms experienced
during physical activity, and a higher need for adaptations during physical activity.
Step 3: assess the patients’ understanding of the draft PROactive PRO instrument
After translating the item lists into the study languages, a first round of cognitive debriefings (n514) was
conducted in December 2010 and January 2011.
Patients suggested further clarifying the concept of physical activity in the introduction. In addition, some
terms were difficult to understand and needed rephrasing into more user friendly terms. Also, some
response options were insufficiently discriminating (e.g. referred to almost the same degree of intensity) and
revisions of response options were suggested. Some items also needed a ‘‘not applicable’’ option (e.g. if
patients don’t have stairs, they should be able to leave questions referring to the climbing stairs blank).
Analysis and modification continued until consensus within the team was reached.
The main comments during the second round of debriefings (n522) referred to the response options: some
items provoked a yes/no response and needed to be rephrased in order to be suitable for a five-point
response option. Additional changes to the response options for the item on walking were suggested. The
daily and 7-day recall period was deemed appropriate by the majority of patients. Patients’ suggestions were
integrated and discussed until consensus was reached on the final item list for both versions of the PRO
(fig. 1). Flesch Reading Ease was 81 for the daily and 86 for the clinic visit items, corresponding with to
reading level of an 8–9-year-old child, indicating that the items are easy to understand by patients with very
low education and/or literacy.
Discussion
Based on direct patient input, we designed an innovative conceptual framework to understand experience
with physical activity from the patients’ experience. This provided the necessary conceptual basis to generate
items for two PRO tools to measure physical activity in patients with COPD. Although the ISPOR
guidelines on establishing content validity were not available at the start of our qualitative studies, we
succeeded to rigorously adhere to all methodological requirements needed to demonstrate content validity
of newly designed PRO instruments [13, 14]. Joint efforts between academia, the European Federation of
Pharmaceutical Industries and Associations partners, patient and professional organisations, and a small-
medium enterprise made this labour-intensive work possible.
Until now, few qualitative studies on patients with COPD have been conducted and focus almost exclusively
on living with a chronic illness or symptom experience [36, 37]. Yet, looking closer at the themes addressed
it becomes obvious that patients also complained about reduced ability to execute their daily activities,
symptom burden while being active and the social and emotional consequences of reduced physical activity.
In contrast to our qualitative studies, none of these studies specifically focused their discussion guide on
physical activity. This might, in part, explain why adaptations emerged as a prominent theme during our
qualitative studies, alongside the level of physical activity and symptoms experienced while being active.
Interestingly, patients had similar experiences irrespective of demographic characteristics, severity of illness
or country of origin, suggesting that physical activity is most likely a universal concept that is relevant to the
majority of patients with COPD. Admittedly, although the large sample size, the extensive phenotyping and
the multinational nature of our qualitative studies are major strengths of our work, we don’t know if
patients from other countries or continents have similar experiences. However, unpublished data of focus
groups with US patients on a related concept (i.e. limitations in physical activity) yielded similar themes,
strengthening our conviction on the concept’s generalisability. Moreover, international members from the
project’s Patient Input Platform, as well as clinical experts participating in the advisory board, all endorsed
REHABILITATION | F. DOBBELS ET AL.
DOI: 10.1183/09031936.00004814 9
the relevance of these overarching themes, as well as the items. Readability of the item lists, which is usually
not evaluated in other self-reported instruments, is excellent, guaranteeing that patients with very low
literacy will also be able to complete the PROactive PRO instruments. Future steps include quantitative
work to confirm the conceptual framework, establish a conceptual model, select the most appropriate items
and demonstrate further validation. This will be done in compliance with existing guidelines for PRO
instrument development. As the item lists are currently only available in English for UK, Dutch for Belgium
and the Netherlands and Greek for Greece, culturally sensitive translations for .50 languages are planned
once the item selection process is completed. The PROactive consortium will also engage in discussions
with regulatory authorities (FDA and EMA) to ensure the PROactive tools fulfil all criteria for inclusion in
future claims of effectiveness of pharmacological and non-pharmacological interventions.
In conclusion, our qualitative studies help to understand the experience of physical activity from the
patients’ perspective. The design of the conceptual framework and the methodological rigor followed to
generate items capturing relevant themes and document content validity will most likely spin off in PRO
tools that, for the first time, are able to adequately capture this important concept.
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